Treat to target in rheumatoid arthritis

Authors

  • Gustavo Casado Jefe del Servicio de Reumatología del Hospital Militar, Buenos Aires.
  • Paula Alba Servicio de Reumatología del Hospital Córdoba. Cátedra de Medicina I. UHMI 3. Universidad Nacional de Córdoba.

DOI:

https://doi.org/10.31053/1853.0605.v67.n4.22564

Abstract

The principle of "Protein targeting" includes an indispensable approach in the prevention of complications of some of the most prevalent diseases such as diabetes, hypertension and coronary artery disease. These diseases lead to high mortality and their preventive treatment should be a public health priority.

Downloads

Download data is not yet available.

References

Staessen JA,Wang JG, Thies L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001;358:1305-15.

Cannon CP. The IDEAL cholesterol : lower is better. JAMA 2005;294: 2492-4.

Smolen JS, Aletaha D, Bijlsma JWJ, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69: 638-642.

Schoels M, Knevel R, Aletaha D, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature research. Ann Rheum Dis 2010;69: 638-42.

Prevoo ML, van `T Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:44-8.

Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol 2007; 21: 663-75.

Downloads

Published

2010-12-07

How to Cite

1.
Casado G, Alba P. Treat to target in rheumatoid arthritis. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2010 Dec. 7 [cited 2024 Jul. 17];67(4):133-4. Available from: https://revistas.unc.edu.ar/index.php/med/article/view/22564

Issue

Vol. 67 No. 4 (2010)

Section

Editorial

License

The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).